Clinical trial B9991033
A phase 1b/2 study to evaluate safety and clinical activity of Avelumab in combination with Binimetinib with or without Talazoparib in patients with locally advanced or metastatic ras-mutant solid tumors
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/2 |
| Academic trial | Non |
| Sponsor | Pfizer |
| EudraCT Identifier | 2018-000124-34 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03637491 |
| Inclusion criteria | KRAS/RAS mutation |
| Last update |